Intestinal calcium malabsorption in postmenopausal osteoporotic women
is often linked indirectly to decreased serum 1,25(OH)2vitamin D or to
intestinal resistance to its action, rather than directly to the low
circulating estrogen that results following menopause. The studies pre
sented indicate that the intestinal mucosal cells of rats contain estr
ogen receptor immunoreactivity, express the mRNA for estrogen receptor
s, and respond directly to 17beta-estradiol with enhanced calcium tran
sport that is suppressed by gene transcription and protein synthesis i
nhibitors. These findings suggest that estrogen has a physiological ro
le in the regulation of intestinal calcium absorption and that its def
iciency in postmenopausal osteoporosis, and following therapeutic ooph
orectomy, may result directly in calcium malabsorption that is believe
d to be an important factor in the bone loss that occurs in these cond
itions.